Novavax

4 Stories

US Could Soon Have a 4th COVID Vaccine Option
FDA Clears 4th
COVID Vaccine Option
UPDATED

FDA Clears 4th COVID Vaccine Option

Novavax shot has been approved for adults

(Newser) - Update: The US is getting another COVID-19 vaccine choice. The Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the US and the company hopes the protein-based vaccine will become...

Now, a 4th Vaccine Sees Strong Efficacy

Novavax says its vaccine has 90.4% overall efficacy, with 100% at preventing severe disease

(Newser) - More good news on the COVID vaccine front: A fourth company now has a strong candidate for availability in the US. Per the New York Times , the Novavax vaccine has shown an overall efficacy of 90.4% during a phase 3 trial in the US and Mexico, with 100% efficacy...

There's a New Vaccine Contender
There's a New
Vaccine Contender
the rundown

There's a New Vaccine Contender

Novavax's COVID-19 vaccine appears 89% effective based on early study results

(Newser) - Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work—though not as well—against new mutated versions of the virus circulating in that country and South Africa. The announcement comes amid worry about...

New Vaccine Candidate Is Getting High Praise

One from Novavax 'is the first one I’m looking at and saying, ‘Yeah, I’d take that,' says virologist

(Newser) - Another coronavirus vaccine candidate is advancing in clinical trials, and the New York Times coverage about it carries this notable quote from a virologist: "This is the first one I’m looking at and saying, 'Yeah, I’d take that." The quote is from John Moore of...

4 Stories
We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.